Dr Mark Lyons

Mark holds a PhD in Biochemistry from the University of Oxford. He has a background in assay and platform development and industrialisation in the areas of microfluidics, cellular biology, immunoassay and clinical chemistry. Mark Lyons has been CEO of Hooke Bio since it spun out of the University of Limerick.